Cellular Biomedicine Group

21Mar

2017 Annual Meeting

14Mar

Full-Year 2016 Financial Results and Recent Operational Progress

27Feb

CBMG Awarded $2.29 Million Grant from the California Institute for Regenerative Medicine

7Feb

CBMG to Present at the 19th BIO CEO & Investor Conference on February 13, 2017

9Jan

Phase I Trial (CALL-1) for C-CAR011 in Adult Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia (ALL) in China

4Jan

Upcoming Presentation at the 9th Annual Biotech Showcase in San Francisco

3Jan

Expansion of Cell Production to Produce CAR-T Therapies

9Dec

Three-Month Interim Safety Data from Phase I Clinical Trial for AlloJoinTM

29Nov

CBMG Approved to Commence Phase I Trial for C-CAR011 in Patients with Refractory Diffuse Large B-cell Lymphoma (DLBCL)

28Nov

CBMG to Present at the 2016 World Stem Cell Summit